Podcasts about md anderson cancer center

— Today's conversation is about a health issue that affects millions of families but is rarely talked about openly. While it primarily impacts men, it often becomes a shared experience for couples. If your partner is waking up several times a night to use the bathroom, struggling with urinary symptoms, or simply saying, "It's just part of getting older," this episode is for you. Benign prostatic hyperplasia, or BPH, is an incredibly common condition as men age, yet many delay seeking help—even though effective treatments are available. The result isn't just interrupted sleep for them; it can affect the well-being, rest, intimacy, and quality of life of both partners. Today, we'll explore what BPH really is, the signs to look for, how to start compassionate conversations with a loved one, and the treatment options that can help men regain comfort, confidence, and a better quality of life. Joining us today is urologist Dr. Sravan Panuganti, who specializes in men's urologic health and is passionate about helping patients find effective, personalized solutions so they can get back to living life more fullyValeria sits with Dr. Sravan Panuganti — He is a urologist with Carolina Urology Partners and an assistant professor in urology at the Virginia College of Osteopathic Medicine in Spartanburg, S.C. Dr. Panuganti completed his college education at the University of Pittsburgh. He then went on to medical school at the Philadelphia College of Osteopathic Medicine and completed his residency in urological surgery at Jefferson New Jersey Hospitals in Southern New Jersey, followed by a fellowship in men's sexual medicine at MD Anderson Cancer Center and University of Texas Health Science Center in Houston, Texas. He is also a fellow of the American College of Osteopathic Surgeons. His specialty interests in urology include benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). He believes in early intervention for BPH and is trained in a variety of treatment options. He lives in Charlotte with his wife, two kids, and dog. To learn more about Dr. Sravan Panuganti and his work, please visit: https://www.laborie.com/patients/conditions/optilume-for-bph/

In this episode of the Epigenetics Podcast, we talked with Kunal Rai from MD Anderson Cancer Center about his work on active DNA demethylation and its role in cancer progression. A major part of the conversation covers his postdoctoral work on active DNA demethylation. He describes how he identified an AID-MBD4-based mechanism, later supported by GAD45, and how this work showed a role for DNA demethylation in early neuronal differentiation and in colon cancer initiation. We then discuss his move into his own lab and his work on melanoma progression. He explains how he used broad epigenomic profiling, chromatin state analysis, and 3D chromatin methods to study enhancers and chromatin organization, and how these approaches helped reveal changes linked to cancer progression. Another topic is his work on epigenetic regulators such as RNF2 and KMT2D. He describes findings on polycomb and trithorax-related factors, including tumor-suppressive roles for KMT2D in melanoma and lung cancer, and how KMT2D loss affects cell phenotype and metabolism. Finally, we talk about lab organization, collaboration, and newer technologies. He says his group works across multiple cancer types and increasingly includes immunology, single-cell methods, spatial epigenomics, and clinical translation, while still using ChIP-seq, CUT&RUN, and CUT&Tag where appropriate. References Fiziev, P., Akdemir, K. C., Miller, J. P., Keung, E. Z., Samant, N. S., Sharma, S., Natale, C. A., Terranova, C. J., Maitituoheti, M., Amin, S. B., Martinez-Ledesma, E., Dhamdhere, M., Axelrad, J. B., Shah, A., Cheng, C. S., Mahadeshwar, H., Seth, S., Barton, M. C., Protopopov, A., Tsai, K. Y., … Rai, K. (2017). Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression. Cell reports, 19(4), 875–889. https://doi.org/10.1016/j.celrep.2017.03.078 Terranova, C. J., Tang, M., Maitituoheti, M., Raman, A. T., Ghosh, A. K., Schulz, J., Amin, S. B., Orouji, E., Tomczak, K., Sarkar, S., Oba, J., Creasy, C., Wu, C. J., Khan, S., Lazcano, R., Wani, K., Singh, A., Barrodia, P., Zhao, D., Chen, K., … Rai, K. (2021). Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy. Cell reports, 36(3), 109410. https://doi.org/10.1016/j.celrep.2021.109410 Related Episodes Epigenetic Signatures During Aging and Cancer (Alena van Bömmel) Epigenetic Mechanisms in Breast Cancer (Luca Magnani) The Effect of Histone Demethylases on Gene Expression and Cancer Cell Stability (Johnathan Whetstine) Contact Epigenetics Podcast on Mastodon Epigenetics Podcast on Bluesky Dr. Stefan Dillinger on LinkedIn Active Motif on LinkedIn Active Motif on Bluesky Email: podcast@activemotif.com

This mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This third episode highlights the Hepato-Pancreato-Biliary cancer operative standard.Hosts:Eliza W. Beal, MD, FACS (X: @ElizaWBealMD) is a Hepato-Pancreato-Biliary surgeon at the Barbara Ann Karmanos Cancer Institute in Detroit. She is also an associate professor of Oncology and Surgery at Wayne State University School of Medicine.Morgan Jackson, MD is a general surgery resident at the Detroit Medical Center and Wayne State University in Detroit, MI.Daniel Nelson, MD, FACS, FSSO (X: @DWNelsonHPB) is a Hepato-Pancreato-Biliary surgeon at the University of Tennessee Health Science Center - Chattanooga.Hop Sanderson Tran Cao, MD, FACS (X: @HopSTranCao) is a Hepato-Pancreato-Biliary surgeon at MD Anderson Cancer Center. Guest:Alice Wei, MD is a Hepato-Pancreato-Biliary surgeon at Memorial Sloan Kettering and associate professor of surgery at Weill Cornell School of Medicine. Dr. Wei contributed to the development of the operative standards for HPB surgery. Learning Objectives: The goals of this podcast are to provide education about the standards, generate discussion, and offer technical pearls to both oncologic specialists and general surgeons, to all of whom these standards apply. In this podcast we discuss the operative standards for liver resection for hepatocellular carcinoma, which includes that the surgeon should: (1) perform a thorough inspection of the liver and abdomen, either laparoscopically or open, including performing liver ultrasound, and (2) should resect all lesions to macroscopically negative margins, preferably with an anatomic resection. Our guest Dr. Wei also provides technical tips, pearls for improving skills performing and interpreting liver ultrasound, and discusses the role of lymphadenectomy in patients with hepatocellular carcinoma. References: Operative Standards for Cancer Surgery, Volume 3: Sarcoma, Adrenal, Neuroendocrine, Peritoneal, Urothelial, Hepatobiliary https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewOBGYN Oral Board Review Coures: https://behindtheknife.org/course/obgyn-oral-board-reviewEPA Playbook: https://behindtheknife.org/course/epa-playbookSurgical Instrument Flashcards: https://behindtheknife.org/course/surgical-instrument-flashcardsABSITE Review: https://behindtheknife.org/course/absite-2026-exam-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this Editor's Special episode of The HemOnc Pulse, MD Anderson Cancer Center's Naval Daver, MD, and Naveen Pemmaraju, MD, discuss MDS/MPN overlap conditions and research examining combination therapy with ruxolitinib and azacitidine (AZA), including its potential to improve disease response, symptom control, and outcomes.

This week we're sharing something special that was previously only available on Substack: Jonathan's conversation with Meredith Sprengel, Research and Program Director for the Subtle Energy Funders Collective and Fellowship Director for the Biofield Fellowship Research Program. Meredith studies what most people would call energy healing — someone holds their hands over you, or sends an intention, and the body drops into a deep state of rest. In that state, curious and sometimes miraculous things start to happen.Science can already measure the electrical field your heart and brain give off, and the faint light your cells emit. But what about a field that connects all of us? And what if it's the missing piece in how the body heals itself?Meredith walks us through a preclinical study at MD Anderson Cancer Center where a specific energy healing practice stopped the growth of pancreatic cancer cells. She also describes her own research in the Netherlands, where people receiving healing showed an exponential rise in biophoton emissions — the faint light our cells give off when they're metabolically active. A mitochondrial researcher who reviewed the data said it resembled what you see in someone who just went for a run.Meredith has interviewed many healers who describe scanning the body and feeling spots that are heavy, hot, or stuck — places where old emotional pain is believed to be held. What her research has found is that healing rarely looks like pain suddenly disappearing. More often, a person's relationship to that pain changes, and connection to other people and a sense of meaning seem to play a role in that shift.So how does it actually work? Some healers say they're channeling god, source, or consciousness. Others describe clearing blockages of stuck energy. And others say they're not doing the healing at all — just giving the body space to do what it already knows how to do.Meredith and her co-host Ivy Ross explore all of this in their six-part podcast series, Phenomena: The Science and Stories of Energy Healing, sitting down with healers, people who've received healing, and the scientists studying what's actually happening.Energy healing has been practiced for centuries. Science is finally starting to catch up!Watch the Stuart Fails to Save the Universe Official Podcast on HBO Max, the HBO Max YouTube channel, or listen wherever you get your podcasts. https://link.mgln.ai/StuartVisit drinkag1.com/BREAKDOWN and get a FREE AG1 Flavor Sampler and a FREE bottle of Vitamin D3 + K2 in your Welcome Kit with your first AG1 subscription order.Get your annual IANDS Conference tickets at https://conference.iands.org.Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BialikBreakdown.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube.com/mayimbialik⁠⁠⁠See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Improving patient access requires more than new processes. It also requires clinicians, administrators, and healthcare leaders to work toward a shared goal. In Part 2 of our conversation, Victor Hassid, MD, Associate Vice President of Access Strategic Operations at MD Anderson Cancer Center, discusses how organizations can align teams, overcome operational challenges and begin putting a patient safety approach to access into practice. You can listen to the first half of the conversation here. You can find Dr. Hassid's article in JAMA here. (paywall) Hosted on Acast. See acast.com/privacy for more information.

Healthcare organizations have spent decades working to improve patient safety, but those efforts have traditionally focused on what happens after a patient enters the healthcare system. Dr. Victor Hassid, Associate Vice President of Access Strategic Operations at MD Anderson Cancer Center, joins the podcast to discuss why he believes patient safety begins much earlier and why delays and breakdowns in access should be viewed through the lens of patient safety. You can find Dr. Hassid's article here. (paywall) Hosted on Acast. See acast.com/privacy for more information.

On this Make a Difference Minute, I have Katie Humphres-Cagle with Barking Cow Farms as she shares the heart behind a special community event honoring Maddie Bishop while supporting Cooper Terry and his mother as they continue their battles with cancer. Katie encourages people to visit Fight with Maddie and learn about a young girl whose smile never seemed to fade, even through the hardest days. She says Maddie's story isn't defined by sadness, but by courage, joy, and the example she left behind. Those who knew her remember a warrior whose positive spirit inspired everyone around her. The event will also benefit Cooper Terry, who was diagnosed with cancer as a teenager. During his treatment journey at MD Anderson Cancer Center, his mother received devastating news of her own—she, too, had cancer. Today, the fundraiser is helping ease the financial burdens both families continue to face through medical treatments, travel, and everyday expenses. The Back to School Jeep Jam will be held Saturday, August 8th, from noon until 8p at Barking Cow Farms, located at 17446 Highway 278 in Brilliant, Alabama. The day will feature family activities, entertainment, and an opportunity for the community to come together in support of two remarkable families. This MADM is brought to you by J. Calvert Farms, proudly supporting stories and the people who make our communities strong. Real stories. Real people. Real impact. News That Unites!™️

In this episode of SurgOnc Today, Dr. Patricio Polanco from Atrium Health Wake Forest University School of Medicine and Dr. Rebecca Snyder from MD Anderson Cancer Center, Chair and Vice-Chair of the HPB Disease Site Working Group, are joined by Dr. Caitlin Hester from University of Miami and Dr. Greg Sacks from NYU Grossman School of Medicine. On today's episode, we will be discussing some of the most exciting research and topics discussed at this year's AHPBA 2026 annual meeting in Miami, Florida. Abstracts: https://www.sciencedirect.com/journal/hpb/vol/28/suppl/S1

In this episode of the Oncology Brothers podcast, we dived deep into the complexities of treating multiple myeloma, focusing on two challenging cases from the community. Joined by experts Marco Davila, MD PhD, from Roswell Park Comprehensive Cancer Center and Krina Patel, MD MSc, from MD Anderson Cancer Center, they discuss the nuances of treatment options for patients experiencing disease relapse post-transplant and disease progression while on maintenance therapy.   Key topics included: The importance of thorough workup and repeat cytogenetics in high-risk multiple myeloma patients The debate between CAR T-cell therapy and bispecific antibodies as treatment options Strategies for managing patients with comorbidities and the role of shared decision-making in treatment planning Insights into the side effects associated with CAR-T and bispecific therapies, including infection risks and neurological symptoms Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o  Follow us on social media: X/Twitter: https://x.com/oncbrothers Instagram: https://www.instagram.com/oncbrothers  Website: https://oncbrothers.com/  Join us as we explored the latest advancements in multiple myeloma treatment and the exciting potential for achieving long-term remission and even cure in select patient populations.   Don't forget to like, subscribe, and hit the notification bell for more insightful discussions on oncology! #MultipleMyeloma, #CARTtherapy, #BispecificAntibody, #RelapsedMyeloma, #OncologyBrothers  

Send us Fan MailWe spend billions of dollars developing drugs to fight cancer - but what if one of the most powerful therapies begins before treatment even starts? Today we're exploring the rapidly growing field of cancer rehabilitation and the science showing that exercise, nutrition, and personalized recovery plans can dramatically improve life before, during, and after cancer.Today's first guest is Dr. Jessica Cheng, MD ( https://www.cityofhope.org/patients/find-a-doctor/jessica-cheng ) one of the country's very few fellowship-trained physicians specializing in cancer rehabilitation medicine, and currently the only fellowship-trained cancer rehabilitation specialist serving Orange County at City of Hope.Dr. Cheng is a board-certified physiatrist whose work focuses on helping cancer patients maximize their strength, mobility, independence and quality of life before, during and after treatment. Her approach combines exercise medicine, physical rehabilitation, pain management, neurological recovery and supportive care into individualized treatment plans designed to remove barriers to successful cancer therapy.After earning her medical degree from Boston University, Dr. Cheng completed residency training at Loma Linda University Health before pursuing one of the nation's premier fellowships in cancer rehabilitation at MD Anderson Cancer Center. Today she is helping shape the future of this emerging field through clinical care, research and physician education.Our second guest is cancer survivor Sharyn Araki.Sharyn's journey encompasses every stage of breast cancer - from discovering a lump and receiving a life-changing diagnosis, through chemotherapy, surgery, radiation therapy and rehabilitation. Throughout that experience she discovered that recovery wasn't simply about surviving cancer - it was about reclaiming her life.Working alongside Dr. Cheng, Sharyn embraced structured exercise and rehabilitation - including an unexpected passion for pickleball - which helped combat debilitating fatigue, rebuild strength and restore confidence. ( https://www.cityofhope.org/orange-county/talking-hope/physical-medicine-and-rehabilitation )Perhaps most remarkably, Sharyn navigated this entire journey while raising seven children, offering a powerful perspective on resilience, family, faith and what it truly means to recover after cancer treatment.#CancerRehabilitation #CancerSurvivor #BreastCancer #CancerRecovery #ExerciseIsMedicine #Prehabilitation #CancerCare #Oncology #IntegrativeOncology #CancerResearch #Fitness #HealthInnovation #QualityOfLife #Stem #MedicalScience #PhysicalTherapy #Wellness #CancerFatigue #CityOfHope #ProgressPotentialPossibilitiesSupport the show

On this episode of The Ty Brady Way, Ty sits down with Tim Harrison, founder of the Coaching Innovation Lab and a man who works at the intersection of human development and technology. Tim is six foot eight, a former Division I basketball player at Rice University, a certified executive coach, and someone who has spent his career figuring out how to help people realize their potential, first through coaching, then through a nonprofit, and now through AI-powered systems that make that work scale in ways that weren't possible even a few years ago. The story starts with a season-ending injury two years into his college basketball career. Tim was an Under Armour All-American, an Adidas All-American, and had every reason to believe the game would take him somewhere. When that door closed, he got access to an executive coach through a university program, and that single experience changed the direction of his life. He started studying psychology, reading personal development books, and saw a clear thread connecting all of it. He knew that kind of transformation was going to matter more to him than anything else he was learning in school. What happened next is one of the more unusual origin stories you'll hear. At 21, Tim got certified as an executive coach through a program run in partnership with MD Anderson Cancer Center, the number one cancer research center in the world. The program was designed for hospital department heads. Tim was in the cohort with them. He was bold enough to ask several of them if he could coach them after the program ended. Most said yes. At 22, he was coaching senior leaders at a major medical institution, building a practice through referrals while simultaneously launching a nonprofit to bring that same kind of coaching to young people in underserved communities. He landed his dream job at a big four consulting firm coming out of college, signed the contract, and then walked away from it. The pandemic, the social justice crisis after George Floyd, and a deep personal conviction that he was meant to contribute more than a corporate ladder could offer pushed him to take a leap with no clear financial path forward. He started the nonprofit anyway. He says the cost of not doing it felt heavier than the risk of doing it, and that calculation has guided most of his major decisions since. Ty and Tim get into AI in a way that actually makes sense for people who are skeptical or intimidated. Tim's framing is simple: AI is not a new subject to study. It's a new tool to reach for while doing the things you're already doing. He breaks down the four zones everyone operates in, from incompetence to genius, and makes the case that AI should be filling the gaps in the lower zones so you can spend more time in the zone where only you can do the work. His line is worth writing down: do what you do best, let AI do the rest. The story that really lands in this conversation happened in 2025 when a political shift in federal funding wiped out the vast majority of revenue from Tim's biggest contract, a multimillion dollar coaching study for biomedical PhD students. He couldn't control what happened. What he could control was how he responded. He used AI to build a custom chatbot trained on all the program's research and operational data, which handled over 500 coach support requests that his team would have otherwise had to address manually. He built an automation that analyzed every coaching session report in real time and populated a live dashboard, eliminating a month-long data analysis process and saving thousands of dollars. He took those savings and launched a new program training entrepreneurs on AI. That program recouped its investment within months. Then a judge blocked the funding cuts and the original program was reinstated. He ended up with two growing revenue streams instead of one, and a leaner, more efficient operation than he started with. He's clear that AI wasn't the hero of that story. The person who knew how to use it was. His advice for anyone who feels stuck is practical and specific. Define where you want to go. Get honest about where you actually are right now, not the catastrophized version, the specific version. Then find the smallest tangible step you would actually take and do it immediately. Don't wait until tomorrow. The momentum that comes from taking even a small action is real, and it compounds. His closing message is the one that ties everything together: who you are is how you prompt. AI multiplies everything, the good and the bad. The only thing you can control is who you are when you're multiplied. So invest in yourself first, then pick up the tools.  

Can music transform the brain and body? Recorded live at the Houston Museum of Natural Science, with 11-time Grammy Award winner Chaka Khan and MD Anderson neurosurgery assistant professor, concert pianist, and music medicine researcher Dr. Mei Rui for a conversation inspired by Rufus's classic “Tell Me Something Good.” Together they explore the neuroscience of rhythm, music as medicine, Chaka's early years in Chicago, the profound role music has played in connecting with her nonverbal nephew Tallon, and how emerging research may benefit neurodivergent communities. This episode was produced in partnership with the Houston Museum of Natural Science, the Chaka Khan Foundation, and MD Anderson Cancer Center.

In this episode of SurgOnc Today, we will discuss the critical infrastructure and institutional support needed to successfully conduct surgical clinical trials. Host Dr. Christina Angeles, surgical oncologist at the University of Michigan and Chair of the SSO Research Committee, is joined by Dr. Hop Tran Cao, HPB surgeon at MD Anderson Cancer Center, and Dr. Melissa Pilewskie, breast cancer surgeon at the University of Michigan – both actively engaged in clinical trials at their respective institutions. Together, they explore the unique challenges surgeons face when initiating and executing clinical trials, how institutional culture and resources shape the research environment, and what it takes to build the infrastructure needed to support high-quality surgical research. From dedicated surgical trials centers and multidisciplinary collaboration to investigator training and fellowship education, this conversation offers practical insights for surgeons at every stage of their career – whether you're just starting out or looking to strengthen your institution's research program.

Send us Fan MailWhat if radiation could become one of the most precise medicines ever invented? Long before radiopharmaceuticals became one of the hottest areas in biotech, today's guest was helping pioneer targeted radiation therapies that seek out cancer cells while minimizing damage to healthy tissue. Today, the field is attracting billions in investment and reshaping oncology.Our guest today is one of the true pioneers of modern targeted radiopharmaceutical therapy.Dr. Ebrahim Delpassand, MD is the Founder, Chairman and CEO of RadioMedix ( https://radiomedix.com/ ), a clinical-stage biotechnology company developing next-generation targeted radioactive diagnostics and therapeutics for cancer.Long before radiopharmaceuticals became one of the most exciting areas in precision oncology, Dr. Delpassand was introducing these therapies to patients who had exhausted every other option. As former Deputy Chairman and Chief of Clinical Nuclear Medicine at MD Anderson Cancer Center, Dr. Delpassand served as Principal Investigator on some of the very first FDA Investigational New Drug programs for Lutetium-177 therapies in the United States, including the nation's first INDs for Lu-177 DOTATATE peptide receptor radionuclide therapy and Lu-177 PSMA-617 therapy.Board-certified in Nuclear Medicine and trained in both pathology and nuclear medicine at Baylor College of Medicine, Dr. Delpassand has authored more than ninety peer-reviewed publications and has spent decades advancing therapeutic nuclear medicine through research, clinical care, and education.But perhaps even more remarkable is his entrepreneurial journey. Nearly twenty years ago, convinced that targeted radiopharmaceuticals represented a fundamentally new way to fight cancer, Dr. Delpassand founded RadioMedix and personally sustained the company through its earliest years while helping build not only innovative therapies, but also isotope production capabilities, cGMP manufacturing infrastructure, and broader access to these life-saving treatments.Today, as radiotheranostics transforms cancer care around the world, Dr. Delpassand joins us to discuss where the field began, where it is heading, and what the next generation of precision radiation medicines could mean for patients.#Radiopharmaceuticals #CancerResearch #CancerTherapy #PrecisionMedicine #Oncology #Radiotheranostics #NuclearMedicine #Biotechnology #Biotech #MedicalInnovation #HealthcareInnovation #TargetedTherapy #AlphaTherapy #Lutetium177 #PrecisionOncology #FutureOfMedicine #CancerTreatment #DrugDevelopment #SciencePodcast #ProgressPotentialPossibilitiesSupport the show

Dr. Lorenzo Cohen, Director of the Integrative Medicine Program at The University of Texas MD Anderson Cancer Center. He's also co-lead author of a study on whether biofield therapy can impact pancreatic cancer. The study demonstrated that biofield therapy could decrease cancer cell proliferation, disrupt mitochondrial function, and reduce metastasis in both cell cultures and animal models, with results comparable to chemotherapy without the side effects. He highlights the challenges to the wider acceptance of this therapy, given the lack of understanding of its mechanism of action and awareness about this growing area of integrative medicine. Lorenzo explains, "So biofield therapies fall into this category of, let's call them treatment modalities in the field of integrative medicine. So integrative medicine can be things like acupuncture, massage, yoga, meditation, nutrition counseling, exercise, things that you could say fall outside of the conventional traditional medical treatments that are within hospital systems. Now, integrative medicine as a whole and integrative oncology in particular have had a huge uptake in hospital systems because of the evidence base in those areas that I just described. The one area that probably remains the most controversial is this area of biofield therapies or often known as energy medicine. I don't actually really like using the term energy medicine because that implies that we know it has something to do with energy, and we're actually not sure exactly what the mechanism is of these therapies. And so what are these? So many of the listeners will have heard of things like Reiki, healing touch, or therapeutic touch."   "External Qigong falls into this category. These are modalities where a practitioner has been trained to be able to work with their own consciousness or their own intention, potentially the biofield of their body. And it is not controversial to know that we as human beings are energetic beings, and we actually do emit biophotons by the nature of being human. But the controversial part is that they are doing that towards a target, whether that be a human being, or, in our case, cells or animals in a laboratory.  And we, in particular, worked with a biofield therapy called the Bengston Cycling Method." #MDAnderson #IntegrativeOncology #BiofieldTherapy #PancreaticCancer #Metastasis #FOXM1 #Mitochondria #PreclinicalResearch #EnergyMedicine #OncologyResearch.  Biofield Therapy Anticancer Living: Transform Your Life and Health with the Mix of Six Download the transcript here

Dr. Lorenzo Cohen, Director of the Integrative Medicine Program at The University of Texas MD Anderson Cancer Center. He's also co-lead author of a study on whether biofield therapy can impact pancreatic cancer. The study demonstrated that biofield therapy could decrease cancer cell proliferation, disrupt mitochondrial function, and reduce metastasis in both cell cultures and animal models, with results comparable to chemotherapy without the side effects. He highlights the challenges to the wider acceptance of this therapy, given the lack of understanding of its mechanism of action and awareness about this growing area of integrative medicine. Lorenzo explains, "So biofield therapies fall into this category of, let's call them treatment modalities in the field of integrative medicine. So integrative medicine can be things like acupuncture, massage, yoga, meditation, nutrition counseling, exercise, things that you could say fall outside of the conventional traditional medical treatments that are within hospital systems. Now, integrative medicine as a whole and integrative oncology in particular have had a huge uptake in hospital systems because of the evidence base in those areas that I just described. The one area that probably remains the most controversial is this area of biofield therapies or often known as energy medicine. I don't actually really like using the term energy medicine because that implies that we know it has something to do with energy, and we're actually not sure exactly what the mechanism is of these therapies. And so what are these? So many of the listeners will have heard of things like Reiki, healing touch, or therapeutic touch."   "External Qigong falls into this category. These are modalities where a practitioner has been trained to be able to work with their own consciousness or their own intention, potentially the biofield of their body. And it is not controversial to know that we as human beings are energetic beings, and we actually do emit biophotons by the nature of being human. But the controversial part is that they are doing that towards a target, whether that be a human being, or, in our case, cells or animals in a laboratory.  And we, in particular, worked with a biofield therapy called the Bengston Cycling Method." #MDAnderson #IntegrativeOncology #BiofieldTherapy #PancreaticCancer #Metastasis #FOXM1 #Mitochondria #PreclinicalResearch #EnergyMedicine #OncologyResearch.  Biofield Therapy Anticancer Living: Transform Your Life and Health with the Mix of Six Listen to the podcast here

Toxicities related to antibody-drug conjugates (ADCs) can significantly impact quality of life for patients with locally advanced or metastatic bladder cancer, but data-driven programs can help multidisciplinary teams manage some of the most challenging adverse events. In this episode, CANCER BUZZ speaks with Cindy Y. Jiang, MD, assistant professor at MD Anderson Cancer Center, about how her institution conducted and implemented research to aid management of rashes and peripheral neuropathy associated with the ADC enfortumab vedotin combined with pembrolizumab. Guest:  Cindy Y. Jiang, MD Assistant Professor Department of GU Medical Oncology MD Anderson Cancer Center Houston, TX "It's important to assemble this team before you start on any sort of journey, because as oncologists, we're definitely not experts in skin rashes or neurological issues, and so you really need to rely heavily on those collaborators." — Cindy Y. Jiang, MD Resources: Bladder Cancer Antibody-Drug Conjugates

What if “energy healing” could be tested—and measured—in a world-class cancer research setting?In this episode of Unpacking Possibility, host Traci Stein unpacks a groundbreaking MD Anderson Cancer Center preclinical study investigating biofield therapy (energy healing) and its reported effects on pancreatic cancer in lab and animal models—including slower growth and spread.Traci shares the findings of this study and discusses them in the broader context of research on biofield therapies (including Reiki, Healing Touch, and Therapeutic Touch). She also shares a personal story about doing Reiki in an operating room for a patient who was undergoing heart surgery and how what she witnessed deepened her perspective on subtle energy. You'll also learn a simple, at-home exercise you can try to begin sensing your own energy field (as well as a friend's).In this episode you'll learn more about:- What the MD Anderson studies found- Why pancreatic cancer research needs new possibilities - Early research showing energy healing could make seeds germinate faster, surgical wounds heal better, and more- A brief look at the Bengston Healing Method and “image cycling” - A simple exercise you can try tonight to explore energy-field sensing Note: This episode is educational and not medical advice. Always consult your healthcare team about diagnosis and treatment.To learn more about Traci's self-paced, online course, “Developing Everyday Intuition,” visit: https://www.drtracistein.com/developing-everyday-intuition-courseTo receive $5 off the price of Traci's course, “Developing Everyday Intuition,” apply code ENERGY5OFF before checkout.“The Everything Guide to Integrative Pain Management,” by Traci Stein, PhD, MPH: https://a.co/d/0fji41kQTo read the MD Anderson paper: https://onlinelibrary.wiley.com/doi/10.1002/cam4.71726

Welcome to the Oncology Brothers podcast! In this episode, we dived into the complexities of chronic myeloid leukemia (CML) through two challenging case studies. Joined by CML experts Dr. Fadi Haddad from MD Anderson Cancer Center and Dr. Gaby Hobbs from Massachusetts General Hospital,  Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ we talked about: The initial workup for diagnosing CML, including the importance of CBC, bone marrow biopsy, and BCR-ABL testing. How to select the most optimal frontline treatment option amongst many available, considering factors like age, comorbidities, and the goal of treatment-free remission (TFR). The role of first-generation TKI, but also how newer TKIs assist in achieving deeper molecular remissions. Strategies for managing treatment breaks and monitoring patients in remission. The role of ponatinib as a pan-BCR:ABL1 inhibitor effective against all known resistance mutations, including T315I, and the optimized response-based dosing strategy to balance efficacy with safety. Tune in for valuable insights on treatment strategies, patient management, and the latest advancements in CML care. Don't forget to like, subscribe, and share your challenging case scenarios for future discussions! #ChronicMyeloidLeukemia, #CML, #TreatmentFreeRemission, #OncologyBrothers

Dr. Mei Rui is a Yale-trained molecular biophysicist, concert pianist, and clinical researcher at MD Anderson Cancer Center, where she runs trials on the measurable effects of music on the human body. In this conversation, we explore what actually happens in the brain the moment music enters it, why the auditory system is the first sense to develop in the womb and the last to go when we die, and how something as accessible as a curated playlist can outperform FDA-approved pharmaceuticals in reducing cortisol.What We Dive Into:1. Music is not a supplement to healing. In the right context, it is the intervention.2. The brain responds differently when you actually show up for the music.3. A longitudinal study in twins showed that three to four years of musical training reduced the risk of Alzheimer's and cognitive decline by 64%, an effect size found in no other single activity.THANK YOU TO OUR SPONSORS:Oneskin — Code KNOWTHYSELF for 15% off - Limited time only!https://oneskin.co/KNOWTHYSELFBASED Body Works — Code KNOWTHYSELF for 20% and a free toiletry bag!https://www.basedbodyworks.com___________00:00 Introduction: Dr. Mei Rui01:44 A Life Between Music and Science05:26 What Happens When Music Enters the Brain07:26 How the Brain Processes Sound and Music11:32 Why Minor Keys Feel Sad: The Science of Tonality14:37 Live Piano Demo: Matching Music to Mood19:06 Music in the Operating Room27:41 Music as Medicine: Clinical Applications29:10 The 32% Cortisol Study31:19 The 16 Compositional Elements of Healing Music35:11 Oxytocin, Familiarity, and the Parasympathetic Response36:18 Timbre and the Cello's Resemblance to a Mother's Voice42:31 Cymatics: Sound Made Visible45:16 The Ancient Roots of Music as Healing47:09 Listening vs. Playing an Instrument55:33 The Musician's Brain: Structural Differences57:46 Music Training and Protection Against Alzheimer's59:44 Music, Empathy, and Neural Synchrony1:01:36 The EEG Experiment: Reading André's Brain Live1:18:21 What the EEG Data Revealed1:22:26 Music, Flow State, and the Disappearance of Self1:26:55 Music as Spiritual Medicine1:30:23 How to Listen More Intentionally___________MORE FROM MEI✨Instagram: https://www.instagram.com/@meiruipianoMORE FROM KNOW THYSELF

Michael Prokopis is the CEO of DARVIS, an AI-powered company transforming healthcare inventory management through real-time visibility and autonomous solutions. Under his leadership, DARVIS is helping health systems use AI and computer vision to improve inventory accuracy, reduce waste, and prevent stockouts. Prior to DARVIS, he held senior roles at institutions including MD Anderson Cancer Center and Steward Health Care. A former US Navy Surface Warfare Officer, Michael has managed $3.2B+ in spending and driven $360M+ in savings through operational transformation and efficiency programs. In this episode… Healthcare supply chains operate under constant pressure, where missing inventory can delay care, increase costs, and create major operational headaches. Yet many hospitals still rely on outdated manual tracking systems that lack real-time visibility. How can AI help healthcare systems reduce waste, prevent shortages, and make smarter inventory decisions? For Michael Prokopis, a healthcare supply chain and operations veteran, the answer lies in combining AI-powered computer vision with real-time inventory intelligence. He highlights how DARVIS uses camera-based AI systems to track thousands of medical products across large hospital systems, reduce manual labor, and prevent costly stockouts. This technology helps healthcare teams automate replenishment, improve forecasting, and respond faster during supply disruptions. He also explains how the system continuously learns and adapts to different healthcare environments, making implementation faster and more scalable. By improving visibility and accuracy, hospitals can operate more efficiently while giving supply chain leaders stronger data for decision-making. In this episode of the Inspired Insider Podcast, host Dr. Jeremy Weisz sits down with Michael Prokopis, CEO of DARVIS, to discuss AI-driven healthcare inventory management. They explore how DARVIS uses computer vision for real-time inventory tracking, the challenges of selling technology to hospitals, and how AI reduces supply chain waste and shortages. Michael also shares lessons from his Navy and healthcare leadership experience.

In this episode, Kim Louise, Medical Intuitive & Holistic Nutritionist, speaks with John Lavack - a gifted energy healer who has worked with clients in over 46 countries for over 30 years. John blends Rapid Image Cycling (a modality developed by the late, great Dr. William Bengston) with a wide range of healing modalities including psychosomatics, neuro-linguistic programming (NLP), bioenergy balancing, intuitive development, and hands-on energy practices. Together we explore how John integrates these tools to help clients shift belief structures, release patterns, and transform health and personal life outcomes all while grounding his work in research settings including the Institute of Noetic Sciences, Beech Tree Labs, and MD Anderson Cancer Center. What you'll discover: • Amazing Stories from decades of helping to heal clients worldwide • How John combines multiple modalities for deeper healing impact • Why shifting belief frameworks matters in energy work • Practical tools like charged cotton & water for energy healing  • How science and energy healing are beginning to intersect • How you can learn Rapid Image Cycling for yourself and to heal others with it - including animals If you're curious about multi-modal energy healing, this conversation offers insight, inspiration, and practical takeaways.  Guest: John Lavack, Energy Healer and Facilitator Contact: (650) 743-4559 Host: Kim Louise, Medical Intuitive and Holistic Nutritionist To schedule a free 15-minute call with me to see if I'm the right fit for your needs, go to: www.kimlouisemedicalintuitive.com Dr. William Bengston's website regarding his research and Rapid Image Cycling classes: https://bengstonresearch.com/ Video with Dr. William Bengston on New Thinking Allowed: https://youtu.be/V-YPt6L45p0?si=RSOen83S8KqtVZhl Dr. William Bengston's video about mummifying bananas: https://youtu.be/0Ca4e3cSi3g?si=dKdV3_YyWupS1PkY Disclaimer: This content is for educational purposes only. It does not diagnose, treat, or cure. Please consult a licensed healthcare provider for medical concerns.

What happens when a cancer research institution invites energy healers into the laboratory? In this special feed takeover, Insights at the Edge presents the debut episode of Phenomena: The Science and Stories of Energy Healing—a new six-part Sounds True podcast hosted by Ivy Ross. In this episode, you'll learn about astonishing research from MD Anderson Cancer Center and the story of one patient whose surgeon saw something they had never seen before. More info at phenomenahealing.com. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to the Oncology Brothers podcast! In this episode, we dived deep into the exciting world of metastatic non-small cell lung cancer (NSCLC) with a focus on targeted mutations in the frontline setting. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ We were joined by Dr. Eric Singhi from MD Anderson Cancer Center, to discuss the latest advancements in treatment options, including: Common EGFR mutations and the benefits of combination therapies over single-agent osimertinib. The role of CNS involvement in treatment decisions and the importance of patient-centered care. Strategies for managing disease progression and the significance of re-biopsy. Insights into ALK-positive disease, including the efficacy of lorlatinib and alectinib. The latest developments in treating rare mutations like NTRK, MET, RET, and HER2. With a wealth of clinical data and practical insights, this episode is packed with valuable information for oncologists and healthcare professionals. Tune in to learn how to navigate the complexities of NSCLC treatment and improve patient outcomes. Don't forget to subscribe for more discussions on oncology topics and share your thoughts in the comments below! #LungCancer, #TargetedTherapy, #PrecisionMedicine, #NGS, #OncologyBrothers

Taking a break from their exploration of the YouCat, Eoin interviews Fr Chris Garrett. Fr Chris is a priest of the Diocese of Elphin ordained three years ago — having previously spent decades as a consultant oncologist at MD Anderson Cancer Center in Houston, Texas. Fr. Chris traces a journey from an Irish upbringing, a […] L'articolo YouChat – Fr Chris's Testimony: Mariathon Special – Fr. Chris Garrett and Eoin Brennan proviene da Radio Maria.

Host Holly Wayment brings us Houston spine surgeon Rex Marco who, after a terrible cycling accident , faced  life-changing paralysis to recovery through mindfulness, the RAIN method, and radical acceptance.   He describes what happened to him and how in one moment everything can change. His work now explores how compassion, mindfulness, and vulnerability can reshape how we live, lead, and heal. In 2019, Dr. Marco sustained a C3–4 fracture-dislocation in a cycling accident, resulting in C2 quadriplegia. Today, he serves as the Chief Medical Ambassador for the Christopher & Dana Reeve Foundation, advocating for research, cure, and improved quality of life for individuals living with spinal cord injury. He is also a certified mindfulness meditation teacher and is passionate about integrating resilience, presence, and emotional healing into medicine, leadership, and life. He's known for creative and transformative teaching and shares that his most profound transformation came through recovery, where he confronted longstanding patterns in how he related to himself and others.  This episode explores how he says acceptance, gratitude, and recovery programs transformed his leadership, clinical practice, and family life, offering actionable tools for cultivating presence and emotional safety. Dr. Rex Marco is an internationally recognized orthopedic spine and musculoskeletal oncology surgeon whose career has centered on caring for patients with complex spinal disorders and tumors. He completed his undergraduate studies at UC Irvine and conducted research at the National Institutes of Health through the Howard Hughes Medical Institute before earning his medical degree from the UCLA School of Medicine. He went on to complete surgical training at Virginia Mason Medical Center, orthopedic residency at UC Davis, and dual fellowships in musculoskeletal oncology at Memorial Sloan Kettering Cancer Center and reconstructive spine surgery at Rush University. Dr. Marco has held leadership roles at MD Anderson Cancer Center, Texas Children's Hospital, Houston Methodist Hospital, and UTHealth Houston, where he serves as Spine Fellowship Director.  

When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufacturing model built around clinical proximity, the global alliance bringing TIL production to regions with no current access, and the next-generation engineered approaches redefining what these therapies can do.Chantale Bernatchez is Head of Process Development at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. If you missed Part 1, she explained how specific activation changes recovered a failing TIL process from 50% to 95% success in heavily pre-treated patients.Topics discussed:How close collaboration with MD Anderson accelerates clinical development and regulatory readiness (03:08)CTMC's approach to process development and adapting to innovative technologies (05:15)The value of partnership-based models versus traditional CDMO-driven approaches (06:24)Global technology transfer: building alliances to expand access to cell therapies, with a case study in Brazil (07:35)Key barriers and solutions for cell therapy manufacturing in new regions (09:41)Practical advice for scientists starting in GMP manufacturing and process development (10:46)Future directions in CAR T and TIL, including logic-gated CARs, engineered TILs, and in vivo therapies (12:24)The importance of continued innovation and collaboration to expand global patient access (17:39)Smart insight:The choice of manufacturing partner in cell therapy is not a logistics decision. It is a process development decision. CTMC's collaboration-based model exists because many early-stage developers arrive without a process robust enough to hand over. For scientists in small or mid-sized companies, engaging that kind of partnership too late, or on purely transactional terms, is one of the most avoidable risks in early clinical development.If you're interested in exploring further the concepts we touched on, such as cell therapy manufacturing, process control, and scaling living therapies—take a look at these related discussions:Episodes 125 - 126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiEpisodes 109 - 110: Spinning Like Earth: Designing Low-Shear Bioreactors for Better Cell Culture with Olivier DetournayEpisodes 105 - 106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerConnect with Chantale Bernatchez:LinkedIn: www.linkedin.com/in/chantale-bernatchez-22b09511CTMC website: www.ctmc.comSupport the show

The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the hard way, watching the same manufacturing process succeed brilliantly with one donor and fail completely with the next. In this episode, she explains why starting material variability is the defining challenge of cell therapy manufacturing, and what it actually takes to build a process robust enough to survive it.Chantale Bernatchez is Head of Process Development at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. She holds a PhD in immunology and has spent two decades advancing T cell therapy from early research programs at MD Anderson to GMP-compliant clinical manufacturing. She holds four patents in adoptive cell therapy.Key topics discussed:Personal journey: from immunology PhD in Quebec to cell therapy leadership in Houston (04:25)Evolution of TIL therapy at MD Anderson, including manufacturing innovations to overcome declining T cell yields (06:14)The fundamental differences between traditional medicines and cell-based immunotherapies (10:01)Unique manufacturing complexities for autologous therapies, including batch variability and process standardization (11:19)Strategies to address decreased cell fitness in heavily pretreated patients, including changes in cell activation and culture conditions (13:57)Key learnings from the CAR T and TIL manufacturing process: balancing process duration, cell fitness, and product yield (16:28)Mechanistic differences between CAR T and TIL therapies and their implications for efficacy and resistance (17:58)The limits and risks of automation in cell therapy manufacturing—balancing manual vs. automated processes (24:04)Why moving between manufacturing platforms raises challenges in comparability and clinical outcomes (25:44)The ongoing search for critical cell quality attributes that correlate with patient response (27:00)In part two, Chantale goes deeper into next-generation approaches, technology transfer, and what needs to change to broadly expand patient access.Smart insight: In cell therapy, manufacturing isn't just a production step. It defines the therapy itself. Because each patient's starting cells are unique, even subtle changes in the process can significantly alter clinical outcomes.If you're interested in exploring further the concepts we touched on—such as cell therapy manufacturing, process control, and scaling living therapies—take a look at these related discussions:Episodes 125 - 126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiEpisodes 109 - 110: Spinning Like Earth: Designing Low-Shear Bioreactors for Better Cell Culture with Olivier DetournayEpisodes 105 - 106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerConnect with Chantale Bernatchez:LinkedIn: www.linkedin.com/in/chantale-bernatchez-22b09511CTMC website: www.ctmc.comSupport the show

In this episode of Bright Spots in Healthcare, recorded live at the ViVE 2026 conference, Eric Glazer sits down with Dr. Pavitra Krishnamani from MD Anderson Cancer Center to explore what it actually takes to build scalable digital health systems. As both a practicing emergency physician and digital health innovator, Dr. Krishnamani brings a frontline perspective to one of healthcare's biggest challenges: why so many digital health tools fail to scale, and what separates technologies that succeed from those that don't. While the industry continues to invest heavily in AI, wearables, telehealth, and other digital tools, many health systems are still struggling with fragmented solutions, low adoption, and limited real-world impact. The path forward isn't more tools, it's better systems.  In this episode, you'll learn: Why workflow integration matters more than features in digital health adoption How AI, wearables, telehealth, VR, and EHRs must work together as a connected ecosystem What health systems should evaluate before bringing in new technology, including ROI, maintenance, and unintended consequences The role of human-centered design in building solutions clinicians will actually use  Why adoption fails without clinician buy-in, flexibility, and cultural alignment How to design more effective pilots and avoid common implementation pitfalls Why education and mindset are critical to scaling AI and digital health What it takes to move from siloed tools to scalable, system-level transformation Key Takeaway: "Education begets innovation" - Pavitra P. Krishnamani, MD. Scalable digital health isn't about deploying more technology, it's about aligning technology, workflows, and people into systems that actually work in practice. Learn More from Dr. Krishnamani: http://pavitramd.com/. Dr. Krishnamani expands on many of these ideas in her upcoming book: Home is Where the Health Is: How Digital Innovation and Technological Advances are Transforming Healthcare and Wellness. The book explores how technologies like AI, wearables, telehealth, and data systems are coming together to reshape healthcare delivery and move care closer to where patients live their daily lives. Connect with Dr. Krishnamani: Instagram: https://www.instagram.com/docpavitra  LinkedIn: https://www.linkedin.com/in/pavitra-krishnamani   Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business through credibility building content and trusted executive relationships, email hkrish@brightspotsventures.com About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.

This mini-series on Behind the Knife delves into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program and Cancer Surgery Standards Program. This episode highlights sentinel lymph node biopsy for breast cancer.Hosts:- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center.- Lauren Postlewait, MD, FACS, is an Associate Professor of Surgery at Emory University School of Medicine and is the Medical Director of the Breast Center at Grady Memorial Hospital in Atlanta, GA.- Chantal Reyna, MD, FACS (@kprgrl3) is a Breast surgical oncologist at Loyola University Medical Center in Chicago, IL and serves as the oncology clinical lead for the breast service line.Guest:- Susan E. Pories, MD, FACS (@SusanPoriesMD) is a professor of surgery, vice chair for quality and safety, and director of the Rutger's Breast Center at the University hospital. Learning Objectives: -       Understand the definition and identification of axillary sentinel lymph node. -       Understand the technique for injecting tracer or dye to perform sentinel lymph node biopsy. -       Understand the importance of preincision drainage evaluation and transcutaneous localization.-       Understand techniques to minimize seroma formation.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colonhttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSBSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 2010 Oct;11(10):927-33.https://pubmed.ncbi.nlm.nih.gov/20863759/Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection J Clin Oncol. 2016 Apr 1;34(10):1072-8.https://pubmed.ncbi.nlm.nih.gov/26811528/The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis World J Surg. 2012 Sep;36(9):2239-51. https://pubmed.ncbi.nlm.nih.gov/22569745/Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer Am J Surg. 2005 Oct;190(4):557-62.https://pubmed.ncbi.nlm.nih.gov/16164919/Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial JAMA Oncol. 2023 Nov 1;9(11):1557-1564.https://pubmed.ncbi.nlm.nih.gov/37733364/Choosing Wisely GuidelinesSociety of Surgical Oncology. Released 2016 July 12; last updated 2020 November 13. Choosing Wisely: Five Things Physicians and Patients Should Question.https://surgonc.org/wp-content/uploads/2020/11/SSO-5things-List_2020-Updates-11-2020.pdfPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewOral Board Simulator: https://app.behindtheknife.org/oral-board-simulatorTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of the Oncology Brothers podcast, we dived deep into the complexities of pancreatic cancer treatment with Dr. Shubham Pant, a GI medical oncologist at MD Anderson Cancer Center. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Join us as we explored: • The challenges of diagnosing and treating pancreatic cancer, particularly in metastatic settings. • The importance of germline testing and next-generation sequencing (NGS) in guiding treatment decisions. • The role of neoadjuvant and adjuvant therapies, including FOLFIRINOX and Gemcitabine-based regimens. • Strategies for managing borderline resectable disease and the significance of multidisciplinary care. • The critical aspect of supportive care, including the use of pancreatic enzyme replacement therapy. • Insights into treatment options for metastatic disease, including FOLFIRINOX, NALIRIFOX, and Gemcitabine-Nab-paclitaxel. • The emerging landscape of targeted therapies for KRAS mutations and the potential of pan-RAS inhibitors. Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the evolving treatment algorithms for pancreatic cancer. Don't forget to like, subscribe, and hit the notification bell for more discussions on cancer treatment and care! #PancreaticCancer, #KRASmutation, #NeoadjuvantTherapy, #SupportiveCare, #OncBrothers

The wellness industry has a problem, and Ezekiel Emanuel is one of the few people willing to call it out. In his new book, Eat Your Ice Cream: A Contrarian’s Guide to Living Longer, Healthier, and Happier, the bioethicist, oncologist, and former White House health advisor challenges both the influencers selling unproven supplements and the culture of wellness-as-self-punishment. In this episode, Emanuel makes a compelling research-backed case that the single most powerful determinant of health, longevity, and happiness is social connection, not sleep scores, protein intake, or VO2 max. Drawing on the Harvard Adult Development Study, the longitudinal study, going strong after 88 years, and other research worldwide, he explains why loneliness is biologically dangerous, and why doctors almost never ask about it. He also makes important points about retirement. When 40 hours of purposeful work becomes 40 hours of passive television, the brain pays a price. Emanuel argues that retirement requires deliberate design to replace the cognitive challenge, social contact, and structured schedule that work once provided. And he offers Ben Franklin, inventor of bifocals at 79, and still inventing at 81, as a model for what staying fully alive in later life actually looks like. Ezekiel Emanuel joins us from Washington, DC. ________________________ For More on Ezekiel Emanuel Eat Your Ice Cream: A Contrarian’s Guide to Living Longer, Healthier, and Happier Website ________________________ Bio Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives and the Diane v.S. Levy and Robert M. Levy University Professor. An oncologist and world leader in health policy and bioethics, he is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations. He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act. Dr. Emanuel is the most widely cited bioethicist in history. He has over 350 publications and has authored or edited 15 books. His recent publications include Which Country Has the World's Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel: A Memoir of an American Family (2013). In 2008, he published Healthcare, Guaranteed: A Simple, Secure Solution for America, which included his own recommendations for health care reform.Dr. Emanuel regularly contributes to The New York Times, The Washington Post, The Wall Street Journal, and The Atlantic and often appears on BBC, NPR, CNN, MS NOW and other media outlets. He has received numerous awards, including election to the Institute of Medicine (IOM) of the National Academy of Science and awards from the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He has been named a Dan David Prize Laureate in Bioethics and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, the Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, the President's Medal for Social Justice from Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center, as well as honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry and received his M.D. from Harvard Medical School and a Ph.D. in political philosophy from Harvard University. ________________________ Retirement Podcast Conversations You’ll Also Love   The Good Life – Marc Schulz, PhD Retiring: Creating a Life That Works for You – Teresa Amabile How Not to Age – Dr. Michael Greger _________________________ About The Retirement Wisdom Podcast There are many podcasts on retirement, often hosted by financial advisors with their own financial motives, that cover the money side of the street. This podcast is different. You'll get smarter about the investment decisions you'll make about the most important asset you'll have in retirement: your time. About Retirement Wisdom I help people who are retiring, but aren't quite done yet, discover what's next and build their custom version of their next life. A meaningful retirement doesn't just happen by accident. Schedule a call today to discuss how the Designing Your Life process created by Bill Burnett & Dave Evans can help you make your life in retirement a great one — on your own terms. About Your Podcast Host Joe Casey is an executive coach who helps people design their next life after their primary career and create their version of The Multipurpose Retirement.™ He created his own next chapter after a 26-year career at Merrill Lynch, where he was Senior Vice President and Head of HR for Global Markets & Investment Banking. Joe has earned Master's degrees from the University of Southern California in Gerontology (at age 60), the University of Pennsylvania, and Middlesex University (UK), a BA in Psychology from the University of Massachusetts at Amherst, and his coaching certification from Columbia University. In addition to his work with clients, Joe hosts The Retirement Wisdom Podcast, ranked in the top 1% globally in popularity by Listen Notes, with over 2 million downloads. Business Insider recognized Joe as one of 23 innovative coaches who are making a difference. He's the author of Win the Retirement Game: How to Outsmart the 9 Forces Trying to Steal Your Joy. __________________________ Wise Quotes On Wellness “Wellness should be about joie de vivre — about joy in life. It should not be only self-deprivation…Most of wellness is about don’t do stupid stuff — and most of it, we already know.” On Retirement “Most people when 40 hours of work drops out, 40 hours of TV comes in. Very passive. Not very intellectually challenging. That’s not retirement — that’s a slow decline…We don’t spend nearly enough time thinking about the brain part of retirement. Your brain is probably more important than your money.” On Willpower vs. Habits “If you have to use your willpower every time you do something, you can forget it. You have to make the wellness activity part of your habit. Doing it three to four times a week for about six weeks, that’s about what you need for a new activity to become ingrained.”  

Join Stephen Ibaraki as he sits down with Dr. Caroline Chung, Vice President, Chief Data & Analytics Officer, and Professor at MD Anderson Cancer Center, for an inspiring conversation about transforming medicine through data, technology, and human-centered innovation.In this episode, Dr. Chung shares her incredible journey—from her early years as a second-generation Canadian to leading pioneering initiatives in oncology at UBC, Princess Margaret, and MD Anderson. Discover how her personal experiences, mentorship, and fearless approach to nonlinear career paths shaped her impact in medicine and data science.Career Inflection Points: How early life experiences and family inspired a mission-driven path in medicine.Precision Medicine & Innovation: Dr. Chung's focus on brain tumors, quantitative imaging, and translational research.Leading Change: Creating multidisciplinary clinics, standardizing tumor measurement, and integrating AI in oncology.Data & Technology in Healthcare: Building enterprise-level data governance, exploring digital twins, and leveraging AI, HPC, and quantum computing.Future of Medicine: Overcoming challenges in interoperability, collaboration across sectors, and fostering the next generation of innovators.

Send a textWhat do the latest findings from the 2025 San Antonio Breast Cancer Symposium mean for people living with metastatic breast cancer? In this episode, Dr. Bora Lim of MD Anderson Cancer Center joins us to break down the most impactful research and clinical trial updates from SABCS 2025. Together we will explore advances in hormone receptor positive, HER2-positive disease and triple negative disease and discuss how these updates may influence treatment decisions right now. We also wrap up with an audience Q&A, including questions about GLP-1 medications.Listen in for expert insight, practical takeaways, and clarity on the evolving MBC treatment landscape.

In this episode, medical student Kristen Schill interviews Dr. Subha Hanif and Dr. Obada Obaisi, two physicians specializing in cancer rehabilitation. Dr. Hanif completed her PM&R residency at Mary Free Bed Rehabilitation Hospital and her cancer rehabilitation fellowship at the University of Michigan, and she currently practices at Mayo Clinic. Dr. Obaisi completed his PM&R residency at Rush University Medical Center, followed by a cancer rehabilitation fellowship at MD Anderson Cancer Center, and now practices at Rush University. They discuss the role of cancer rehabilitation within multidisciplinary cancer care, the training pathway into the specialty, and how the field continues to evolve. The conversation also highlights opportunities for medical students to get involved and offers practical advice for those considering cancer rehabilitation as a career.

“Would you risk it all for a baby monkey you've never met?”

Love the episode? Send us a text!What if part of what makes cancer so hard isn't just the diagnosis—but the spaces where care happens?In this eye-opening episode of Breast Cancer Conversations, host Laura Carfang explores how hospital design, architecture, and the built environment directly shape the cancer experience, often in ways patients never realize—but deeply feel.Laura is joined by Abbie Clary, Executive Director of Market Strategies and Growth for Health for All, and a nationally recognized leader in healthcare architecture and experience design. With millions of square feet of cancer and healthcare facilities in her portfolio—including projects at Memorial Sloan Kettering, MD Anderson, and the Shirley Ryan AbilityLab—Abbie pulls back the curtain on how hospitals are designed, who they're designed for, and why women are so often treated as the “outlier.”Together, they discuss trauma-informed design, survivorship-centered care, caregiver inclusion, gender bias in medical spaces, and why healing doesn't only happen through medicine—it happens through dignity, control, and environment.In This Episode, We Talk About:Why hospitals and medical spaces are often designed for a “default male”How architecture impacts anxiety, trauma, and healing for cancer patientsWhat trauma-informed design actually looks like in practiceWhy cancer patients experience healthcare differently than other patientsThe importance of designing for repeat visits, not one-time careHow caregivers and loved ones should be treated as part of the care teamWhy dignity, control, and privacy matter as much as efficiencyGender bias in medical design—from gowns to equipment to workflowsWhy women's pain and discomfort are often minimized in healthcareDesigning cancer centers for survivorship, not just treatmentAbout Today's GuestAbbie Clary, FAIA, FACHA, is the Executive Director of Market Strategies and Growth — Health for All. Her work spans some of the most ambitious healthcare projects in the world, including Memorial Sloan Kettering's new Cancer Care Pavilion, MD Anderson Cancer Center's 2030 facilities master plan, and the Shirley Ryan AbilityLab in Chicago.A nationally sought-after speaker and TEDx presenter, Abbie's work focuses on transforming healthcare through strategic, human-centered design—bridging architecture, culture change, patient experience, and health equity. Her mission is simple but radical: design healthcare spaces that actually support healing, dignity, and belonging. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

Most of us have been trained to think of treating people as a technical problem. If something hurts, we look for the right drug. If something fails, we look for the right procedure. That picture is incomplete.We've built a system obsessed with fixing bodies, while quietly ignoring the inner worlds of the people living inside them. Their fears, their beliefs, their unanswered prayers, and the meaning they're trying to make of suffering.Illness doesn't just attack organs. It raises questions about God, identity, guilt, fear, and loss of control. And when those questions go unanswered, suffering multiplies, no matter how advanced the treatment plan is.Modern medicine has no real language for this kind of pain. It knows how to measure blood pressure, inflammation, and tumor size, but it doesn't know how to sit with grief, spiritual doubt, uncertainty, and loss.Yet when clinicians slow down enough to listen, something shifts. Patients begin to speak about meaning, about God, about unresolved relationships and fears they've never voiced before.And often, that is where real healing starts — the kind of whole-person healing that restores connection, dignity, and a sense of being spiritually held in the middle of suffering.What if some of the deepest healing doesn't come from doing more, but from being more present? How can clinicians learn to care for the soul as intentionally as they care for the body?In this episode, I speak with Dr. Marvin Delgado Guay, a palliative care specialist at MD Anderson Cancer Center. We talk about what it looks like when medicine includes spiritual care in its everyday practice. We explore why “total pain” includes the soul as much as the body, and how healthcare can become not just a place of treatment, but a space for healing, meaning, and connection with God.Things You'll Learn In This Episode Pain isn't always physicalMany symptoms labeled as “medical” are actually expressions of emotional or spiritual distress. What happens when we treat suffering instead of just symptoms?Fixing vs. healingMedicine is trained to solve problems, but some forms of suffering can't be solved, only witnessed. How does presence become a form of treatment?How spirituality shapes medical decisionsBeliefs about meaning, God, and purpose influence everything from treatment choices to end-of-life care, but are clinicians equipped to address this?The power of the “collective soul” in healthcareWhen doctors, nurses, chaplains, and therapists work as one, care becomes something deeper than specialization. What changes when healing becomes a shared human act?Guest BioDr. Marvin Delgado Guay is an internist and Assistant Professor in the Department of Palliative Care and Rehabilitation Medicine at MD Anderson Cancer Center, where he provides symptom control and supportive care for patients with advanced cancer and their caregivers. He completed his internal medicine training at Michael Reese Hospital in Chicago, followed by a fellowship in Geriatric Medicine at Harvard Medical School, and a clinical and research fellowship in Symptom Control and Palliative Care at MD Anderson. Earlier in his career, he coordinated palliative care services and worked within geriatrics at Lyndon B. Johnson General Hospital through the University of Texas Medical School. Dr. Delgado Guay's work focuses on what medicine often overlooks: the full experience of illness. His research explores physical, psychological, and spiritual distress in patients with serious disease, as well as aging-related issues such as frailty and cognition. He has authored and co-authored multiple peer-reviewed publications on symptom burden and spiritual care in advanced cancer, and is deeply committed to improving quality of...

Dr. Shivani Gupta comes from a family of people with diabetes, generation by generation, where she's seen the after-effects of suffering with chronic metabolic disease.  Her new book, The Inflammation Code (launching, distills 20 years of studying Ayurveda into simple pillars you can apply to prevent the level of inflammation and disease we see today. When people tell her, "I have brain fog, I'm tired, my sleep is off, my digestion's off, I have stubborn weight gain…I guess this is just aging," her reply is, "No, it's not aging, it's inflammaging." We had a really excellent, in-depth conversation that covered a lot of ground, from black pepper and the blood-brain-barrier to our detox experiences in India. I hope you enjoy the podcast! In this podcast, Dr. Gupta and I discuss: Her study of Ayurveda, a 5,000-year-old system from India that taught us the circadian clock, modern science discovered what Ayurveda taught 5,000 years ago about living in rhythm with nature The three doshas or constitutions of Vata (air/ether), Pitta (fire/water), and Kapha (earth/water)—understanding your constitution helps customize your self-care practices and diet The circadian clock in Ayurveda teaches that 10:00 to 2:00 PM is Pitta (fire) time, when you're most focused and energetic, and meant to eat your biggest meal 10:00 PM to 2:00 AM is the most important time to be asleep, when Pitta fire cleans and clears inflammation, the lymphatic system, and the glymphatic system (lymphatic system of the brain) Vata people are always in motion and prefer jobs where they don't sit still—they're endurance athletes who can run through the day on coffee, green juice, and crackers (but their homework is three square meals) Pitta people are fiery, passionate leaders who tend to crave hot, oily, spicy fried food…but that's the one thing they shouldn't eat because their digestive fire is already like a bonfire! Kapha people are sturdy, strong, and very grounded, but can struggle with sluggish metabolism, low mood or depression, getting stuck, or not wanting to create change Black pepper increases curcumin absorption by 2,000%—scientists at MD Anderson Cancer Center discovered this, which is why traditional Indian cooking always uses turmeric with black pepper What it feels like to experience a Panchakarma detox in India: "massage that feels like abuse" with paper thongs—Dr. Gupta says, "I can't believe you're allowed to do this to me and I'm paying for it" (both she and I had this experience!) Mental inflammation is the stress we create when forcing ourselves to be healthy; if you force workouts, force protein, force intermittent fasting, the stress alone causes the inflammation you're trying to prevent

You're about to biopsy a renal lesion; should you ablate at the same time? In this episode of the BackTable Podcast, host Michael Barraza talks with Dr. Steven Huang from MD Anderson Cancer Center about building an efficient and effective renal biopsy and ablation service line. --- This podcast is supported by: Varian IntelliBlatehttps://www.varian.com/products/interventional-solutions/microwave-ablation-solutions --- SYNPOSIS Dr. Huang first covers referral patterns and the typical pathway that patients take to end up in his clinic. The discussion covers the types of lesions he treats, imaging requirements, and criteria for patient eligibility. He emphasizes the importance of shared decision making when deciding between active surveillance, interventional treatment, and partial nephrectomy. Dr. Huang explains his preferred procedural approach and ablation modalities, including cryo, microwave (MWA), and radiofrequency ablation (RFA). He shares his experiences with challenging cases and integrating new technologies like histotripsy and the Siemens interventional package. They also discuss the possibility of a preoperative embolization for larger lesions that could be susceptible to the heat sink effect. Both experts emphasize the importance of collaboration with urologists and ensuring patient safety and expectations. They also touch on the future of the field, discussing the use of AI and robotics. --- TIMESTAMPS 00:00 - Introduction 02:17 - Training Programs at MD Anderson03:23 - Referral Patterns for Renal Ablations07:25 - Patient Management and Virtual Consultations10:59 - Ablation Techniques and Device Selection26:44 - Challenges and Complications27:25 - Approach to Lesions Near Renal Vasculature28:02 - Patient Expectations and Urologist Collaboration33:26 - Post-Procedure Care and Patient Recovery35:30 - Managing Recurrences and Multiple RCCs47:17 - Closing Remarks

In this episode of the Oncology Brothers podcast, we discussed two challenging cases focused on Acute Myeloid Leukemia (AML). We welcomed Dr. Naval Daver, a leading expert from MD Anderson Cancer Center, to discuss: therapy-related AML and de novo AML where induction chemotherapy is not an option. Episode Highlights: • Overview of therapy-related AML and its increasing prevalence due to advancements in solid tumor treatments. • In-depth discussion on the prognosis and treatment options for patients with complex cytogenetics. • Comparison of induction treatments: CPX-351 vs. the traditional 7 + 3 regimen, including survival rates and side effects. • Insights into the use of hypomethylating agents combined with venetoclax for older patients with AML, particularly those with NPM1 mutations. • Practical considerations for administering these treatments in both inpatient and outpatient settings. Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode provides valuable insights into the complexities of AML management. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more discussions on treatment algorithms, conference highlights, and the latest FDA approvals! #AcuteMyeloidLeukemia, #TherapyRelatedAML, #DeNovoAML, #TransplantIneligible, #OncologyBrothers

Something New!  For HR teams who discuss this podcast in their team meetings, we've created a discussion starter PDF to help guide your conversation. Download it here https://goodmorninghr.com/EP237  In episode 237, Coffey and DeDe Church discuss recent news items about how shifting economic conditions, technology, and leadership gaps are reshaping the employment landscape.  They discuss the realities of a “low-hire, low-fire” labor market; dehumanizing hiring processes and AI-driven recruiting tools; challenges facing early-career workers and liberal arts graduates; emerging roles created by artificial intelligence; the growing importance of soft skills like problem solving and communication; workforce restructuring, layoffs, and job hugging; employee disengagement and the great detachment; why strong frontline workers often struggle as supervisors; the risks of promoting without leadership training; transparency, feedback, and promotion decisions; and how kindness, accountability, and continuous feedback drive engagement.  Good Morning, HR is brought to you by Imperative—Bulletproof Background Checks. For more information about our commitment to quality and excellent customer service, visit us at https://imperativeinfo.com.   If you are an HRCI or SHRM-certified professional, this episode of Good Morning, HR has been pre-approved for three quarters of a recertification credit. To obtain the recertification information for this episode, visit https://goodmorninghr.com.   Media mentioned in this podcast:  From AI bubble fears to the job market's ‘Great Freeze': Economists answer your biggest questions about 2026  Private-Sector Hiring Turned Positive in December After November Losses   Private Hiring Sank in November, ADP Says  US Bureau of Labor Statistics Occupational Outlook Handbook: Fastest Growing Occupations  The 2026 Job Market Outlook: Where the Jobs Are  Economists Are Studying the Slowing Job Market—and Feeling It Themselves  When Good Frontline Workers Make Bad Supervisors  Is Your Leadership Style Too Nice? The Friendship Recession: The Lost Art of Connecting Use Situation-Behavior-Impact (SBI)™ to Understand Intent  About our Guest:  DeDe Church is an attorney, employee relations counselor, workplace and University investigator, and nationally recognized trainer with more than 30 years of experience. She has trained thousands of employees and managers on how to create a productive, respectful culture for clients ranging from Fortune 50 companies to her favorite local pizza shop. Known for her humor and practicality, DeDe is often invited and then re-invited to deliver her high-energy workshops at distinguished conferences and to create videos for employee onboarding and annual training.  As an expert investigator, DeDe relies upon a depth of knowledge to find the facts without causing unnecessary disturbances. Witnesses often say they feel at ease when talking with her because of her approachable nature. In addition, DeDe is often retained to review investigation procedures and to train in-house HR and University professionals on investigation best practices. In recognition of her skills, DeDe has been retained to testify as an expert witness in employment cases more than 20 times by organizations including Uber, BP, and MD Anderson Cancer Center.  DeDe is a former Senior Assistant Attorney General for the State of Texas in the Civil Rights/General Litigation Division. During almost seven years there, she advised dozens of state agencies on the proper response to employee complaints, represented the State in over 30 trials involving discrimination in the workplace, and successfully argued before the Fifth Circuit Court of Appeals and the Texas Supreme Court. DeDe received the prestigious Presidential Citation from the President of the Texas State Bar in recognition of outstanding service to the citizens of Texas. Her Bachelor of Arts degree is from Louisiana State University, magna cum laude, and she received a Doctorate of Jurisprudence with Honors from the University of North Carolina School of Law in Chapel Hill, North Carolina.  DeDe Church can be reached at www.dedechurch.com https://www.linkedin.com/in/dede-wilburn-church-a71b748/  About Mike Coffey:  Mike Coffey is an entrepreneur, licensed private investigator, business strategist, HR consultant, and registered yoga teacher. In 1999, he founded Imperative, a background investigations and due diligence firm helping risk-averse clients make well-informed decisions about the people they involve in their business. Imperative delivers in-depth employment background investigations, know-your-customer and anti-money laundering compliance, and due diligence investigations to more than 300 risk-averse corporate clients across the US, and, through its PFC Caregiver & Household Screening brand, many more private estates, family offices, and personal service agencies. Imperative has been named a Best Places to Work, the Texas Association of Business' small business of the year, and is accredited by the Professional Background Screening Association.  Mike shares his insight from 25+ years of HR-entrepreneurship on the Good Morning, HR podcast, where each week he talks to business leaders about bringing people together to create value for customers, shareholders, and community. Mike has been rec...

Today, I am excited to speak with Dr. Carl Robinson, Founding Partner at Vantage Leadership Consulting. Carl is a licensed clinical psychologist who has spent the better part of the last 35 years assisting executives and families in preparing for and navigating career-defining moments. His clientele is broad and far-reaching, ranging from non-profit organizations to the Fortune 100, and includes names such as the Federal Reserve System, MD Anderson Cancer Center, Whirlpool, Steel Dynamics, The Hyatt Corporation, and many more. Carl is a highly regarded public speaker, who has authored a number of articles and has frequently been interviewed by various business publications, including the Wall Street Journal. He is a longtime friend, collaborator, and former member of the Advisory Board of FOX. Succession is arguably the most important evergreen topic on the minds of enterprise families and their family offices. Carl shares his views on what is required for success in successions among UHNW families and family offices and talks about the importance of talent assessment as families undertake leadership and ownership succession journeys. Carl offers practical advice for the older generation and those in leadership who are looking to transition control, responsibility, and ownership to the next generation. He also provides invaluable tips and suggestions for the rising gen and those who are poised to step into leadership and fill the shoes of their parents and predecessors. Don't miss this highly instructive conversation with one of the longest-serving, deeply experienced advisor and coach to multigenerational enterprises and family leaders.

This bonus episode is the audio from a Breastcancer.org webinar. Follow-up care after breast cancer is essential. Getting good follow-up care can make a big difference in your long-term health and quality of life. In this Breastcancer.org webinar, you'll find out how often you should see your oncologist after your treatment ends and get other practical advice from our expert panelists and patient advocates. Watch the webinar to get expert advice from the panelists, including:  Marisa C. Weiss, MDChief Medical Officer and Founder, Breastcancer.org Hoda Badr, PhDProfessor, Department of Medicine, Baylor College of Medicine Fumiko Chino, MDRadiation Oncologist, Memorial Sloan Kettering Cancer Center Evelyn Robles-Rodríguez, DNP, APN, AOCNDirector of Outreach, Prevention, and Survivorship, MD Anderson Cancer Center at Cooper Erin Roesch, MDBreast Medical Oncologist, Cleveland Clinic Megan-Claire ChaseBreast Cancer Program Director, SHARE Cancer SupportPatient Advocate Amanda HelmsPatient Advocate Kate RosenblumPatient Advocate Loriana Hernandez-AldamaTwo-Time Cancer Survivor, Award-winning Journalist, Author

Send us a textWhat if cancer didn't have to be eradicated, but could be remembered, monitored, and controlled by the immune system itself?In this episode of Causes or Cures, Dr. Eeks speaks with Dr. Zachary Hartman, the lead researcher who revisited an extraordinary breast cancer vaccine trial conducted over 20 years ago. The trial involved a small group of women with advanced breast cancer. Women who, remarkably, are all still alive today.By analyzing their blood decades later, the research team discovered that these women still carried immune cells capable of recognizing their cancer, suggesting durable immune memory lasting more than two decades. (Study link here.)We discuss:The original breast cancer vaccine trial and what it was designed to do, in plain languageWhat it was like to discover that the women from the trial was still alive more than 20 years laterHow the immune systems of these women continued to recognize cancer cells long after the trialWhat CD27-positive immune cells are and why they matter, explained simplyWhy helper CD4 T cells may be just as important, or more important, than killer CD8 T cells when it comes to cancerWhat happened when researchers combined a CD27-boosting antibody with a cancer vaccine in miceWhat surprised the research team mostThe challenges of translating findings from mice to human trialsWhether cancer could someday be managed long-term by the immune systemHow generalizable this immune memory might be across different cancersWhat this research could mean for how we think about vaccines in a post-pandemic worldThe one key message the researcher hopes the public takes awayWhat's next in this line of researchThis episode offers a rare, hopeful (but scientifically grounded) look at how the immune system may be capable of remembering cancer for decades. Guest Bio: Dr. Zachary C. Hartman is an Associate Professor at Duke University in the Departments of Surgery, Pathology, and Integrative Immunobiology, where he also serves as Director of the Center for Applied Therapeutics and is a member of the Cellular and Molecular Biology and Genetics and Genomics programs. He earned his undergraduate degree from Northwestern University and completed his PhD at Duke University, followed by postdoctoral training in tumor immunology and breast oncology at Duke and the MD Anderson Cancer Center. In 2012, Dr. Hartman returned to Duke to establish a research program focused on tumor immunology and the development of cancer immunotherapies, including therapeutic vaccines, immune agonists, checkpoint inhibitors, antibody-based therapies, and strategies to stimulate anti-tumor immune responses.  Work with me? Perhaps we are a good match. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Follow Public Health is WeirdOr Facebook here.Or X.OnSupport the show

My conversation with Dr Emanuel begins at about 34 minutes Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous soul In Eat Your Ice Cream, renowned health expert Dr. Ezekiel J. Emanuel argues that life is not a competition to live the longest, and that "wellness" shouldn't be difficult; it should be an invisible part of one's lifestyle that yields maximum health benefits with the least work Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives, the Co-Director of the Healthcare Transformation Institute, and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania Perelman School of Medicine. Emanuel is an oncologist and world leader in health policy and bioethics. He is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations.  He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August of 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act (ACA). Emanuel also served on the Biden-Harris Transition Covid Advisory Board. Dr. Emanuel is the most widely cited bioethicist in history.  He has over 350 publications and has authored or edited 15 books. His recent publications include the books Which Country Has the World's Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel: A Memoir of an American Family (2013). In 2008, he published Healthcare, Guaranteed: A Simple, Secure Solution for America, which included his own recommendations for health care reform. Dr. Emanuel regularly contributes to the New York Times, the Washington Post, the Wall Street Journal, The Atlantic, and often appears on BBC, NPR, CNN, MSNBC and other media outlets. He has received numerous awards including election to the National Academy of Medicine, the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He has been named a Dan David Prize Laureate in Bioethics, and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, President's Medal for Social Justice Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center. Dr. Emanuel has received honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. In 2023, he became a Guggenheim Fellow. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry, and received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete   Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Gift a Subscription https://www.patreon.com/PeteDominick/gift Send Pete $ Directly on Venmo  

Isabel González entrevista a la Dra. Silvia Pérez Rodrigo.

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This first episode highlights the colon cancer operative standard. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center. Guest: George Chang, MD, MS, MHCM, FACS, FASCRS, FSSO is a Professor and the interim Department Chair in the Department of Colon and Rectal Surgery at MD Anderson Cancer Center.   Learning Objectives: The extent of colon mobilization and resection depends on tumor location, with high vascular ligation of the tumor-bearing segment to complete adequate regional lymphadenectomy. The technical steps of right colectomy are reviewed, including high ligation of the ileocolic pedicle at the level of the superior mesenteric vein, and the right branch of the middle colic artery if present. Tips and tricks are discussed to identify vascular structures and avoid central vascular injury. Links to Papers Referenced in this Episode Operative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colon https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Kindle edition: https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSB Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomized, controlled, phase 3, superiority trial Lancet Oncol. 2021 Mar; 22(3):391-401. https://pubmed.ncbi.nlm.nih.gov/33587893/ Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol. 2018 Jan;25(1):38-45. https://pubmed.ncbi.nlm.nih.gov/27942902/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Sponsored By: → Cornbread Hemp | For an exclusive offer go to cornbreadhemp.com/drg and use promo code DRG for 30% OFF your first order! → JASPR | For an exclusive offer go to jaspr.co/DRG and get $200 OFF for a limited time. Sign up for our newsletter! https://drchristiangonzalez.com/newsletter/ Episode summary For empaths, introverts, and anyone who feels other people's moods deeply: this episode is for you. Dr. G sits down with Dr. Jason Yuan (ND)—a naturopathic doctor who blends energy healing with practical basics (sleep, minerals, breath, gut care). He explains pranic healing in plain English (think acupuncture without needles) and shares simple habits to use after hard talks, busy rooms, or long days. • Post-conversation reset (60–120s): pause, breathe a little slower through your nose, then say one release line (silently or aloud): “I release what isn't mine.” • Salt routine: in the shower, rub a handful of salt over shoulders/arms and rinse; or take a bath with 1–2 cups of salt to clear that heavy, lingering feeling. • Grounding: spend 5–10 minutes barefoot on grass/earth. No yard? Stand still indoors, feel your feet, and breathe slowly for a minute.• Why sensitive people “catch” the room's mood—and how to turn the volume down• How pranic (hands-off) energy work helps the body reset • Daily rhythm basics (sleep, minerals, steady meals) that make you more resilient About the guest: I'm with Dr. Jason Yuan, a naturopathic doctor who grounds energy practices in physiology—nervous system, breath, minerals, and gut. He cites mind–body research at MD Anderson Cancer Center where a healer's brain-state shifts were linked to changes in cells, and he turns those insights into simple, repeatable routines. Listen now to get the full walkthrough and context behind each step. Timestamps: 0:00 - Introduction 1:36 - Rapid Fire 4:43 - Dr. Yuan's Journey from Skeptic to Energy Healer 8:13 - 25 Years of Eczema: Personal Healing Story 11:57 - What Creates Energy Blocks and Congestion 16:44 - Research: MD Anderson Cancer Study Results 22:12 - Jesus & Collective Consciousness Healing 27:54 - The Three Bodies: Physical, Emotional & Mental 34:31 - Biofield vs Quantum Field Explained 39:30 - Soul as Driver: The Chariot Metaphor 45:07 - Practical Tools: Salt Baths & Energy Hygiene 50:32 - Energetic Cords: How People Drain Your Energy 55:18 - Virtual Sessions & Learning Pronic Healing